• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Probe into White House, PhRMA Dealings on Reform Law Continues


An ongoing federal probe indicates there was a deal between the White House and the Pharmaceutical Research and Manufacturers of America that bound both entities to certain commitments before Congress passed the healthcare reform law.

Under the leadership of Rep. Cliff Stearns (R-Fla.), the House Energy and Commerce Subcommittee on Oversight and Investigations sent a memo (PDF) Wednesday to Republican members of the full panel to provide an update on the subcommittee's investigation. The inquiry aims to answer the following: Did the Obama administration and outside stakeholders make deals that exchanged policy outcomes for public support of the law; if so, who made such deals; was Congress left out of the discussions; what issues were negotiated; and what, if anything, did the White House gain in the arrangement.

Read the full story: http://hcp.lv/JNnAY5

Source: ModernHealthcare.com

Related Videos
Virginia Kaklamani, MD | image credit: uthscsa.edu
Ruben A. Mesa, MD, president and executive director of Atrium Health Levine Cancer Institute and Atrium Health Wake Forest Baptist Comprehensive Cancer Center
Dr Guru Sonpavde
Related Content
© 2023 MJH Life Sciences
All rights reserved.